Werke:
- Characterization and therapeutic targeting of the homologous recombination deficient pancreatic ductal adenocarcinoma subtype
- Immunhistochemische Charakterisierung Atm depletierter Pankreata im Mausmodell des duktalen pankreatischen Adenokarzinoms
- Targeting DNA damage repair mechanisms in pancreas cancer
- Neoadjuvant plus adjuvant or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer - the NEONAX trial (AIO-PAK-0313), a prospective, randomized, controlled, phase II study of...